1. Home
  2. ESQ vs AMPH Comparison

ESQ vs AMPH Comparison

Compare ESQ & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$123.39

Market Cap

941.0M

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.19

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
AMPH
Founded
2006
1996
Country
United States
United States
Employees
N/A
1976
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
1.0B
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
ESQ
AMPH
Price
$123.39
$26.19
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
★ $120.33
$28.38
AVG Volume (30 Days)
175.4K
★ 387.8K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
★ 0.76%
N/A
EPS Growth
★ 14.20
N/A
EPS
★ 2.89
0.81
Revenue
N/A
★ $719,887,000.00
Revenue This Year
$35.15
$6.90
Revenue Next Year
$39.09
$4.64
P/E Ratio
$42.62
★ $32.43
Revenue Growth
★ N/A
N/A
52 Week Low
$92.39
$16.65
52 Week High
$134.65
$29.52

Technical Indicators

Market Signals
Indicator
ESQ
AMPH
Relative Strength Index (RSI) 56.90 77.09
Support Level $103.79 $25.53
Resistance Level $125.40 $29.40
Average True Range (ATR) 2.81 0.88
MACD 0.58 0.17
Stochastic Oscillator 72.38 90.18

Price Performance

Historical Comparison
ESQ
AMPH

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: